424 related articles for article (PubMed ID: 23281850)
1. Proteoglycans and their roles in brain cancer.
Wade A; Robinson AE; Engler JR; Petritsch C; James CD; Phillips JJ
FEBS J; 2013 May; 280(10):2399-417. PubMed ID: 23281850
[TBL] [Abstract][Full Text] [Related]
2. Chondroitin Sulphate Proteoglycans in the Tumour Microenvironment.
Mellai M; Casalone C; Corona C; Crociara P; Favole A; Cassoni P; Schiffer D; Boldorini R
Adv Exp Med Biol; 2020; 1272():73-92. PubMed ID: 32845503
[TBL] [Abstract][Full Text] [Related]
3. DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.
Liao WC; Liao CK; Tsai YH; Tseng TJ; Chuang LC; Lan CT; Chang HM; Liu CH
PLoS One; 2018; 13(6):e0198364. PubMed ID: 29864158
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma.
Phillips JJ; Huillard E; Robinson AE; Ward A; Lum DH; Polley MY; Rosen SD; Rowitch DH; Werb Z
J Clin Invest; 2012 Mar; 122(3):911-22. PubMed ID: 22293178
[TBL] [Abstract][Full Text] [Related]
5. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.
Iozzo RV; Sanderson RD
J Cell Mol Med; 2011 May; 15(5):1013-31. PubMed ID: 21155971
[TBL] [Abstract][Full Text] [Related]
6. Chondroitin sulfate content and decorin expression in glioblastoma are associated with proliferative activity of glioma cells and disease prognosis.
Tsidulko AY; Kazanskaya GM; Volkov AM; Suhovskih AV; Kiselev RS; Kobozev VV; Gaytan AS; Krivoshapkin AL; Aidagulova SV; Grigorieva EV
Cell Tissue Res; 2020 Jan; 379(1):147-155. PubMed ID: 31773303
[TBL] [Abstract][Full Text] [Related]
7. Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology.
Schaefer L; Tredup C; Gubbiotti MA; Iozzo RV
FEBS J; 2017 Jan; 284(1):10-26. PubMed ID: 27860287
[TBL] [Abstract][Full Text] [Related]
8. Measuring Sulfatase Expression and Invasion in Glioblastoma.
Wade A; Engler JR; Tran VM; Phillips JJ
Methods Mol Biol; 2022; 2303():415-425. PubMed ID: 34626397
[TBL] [Abstract][Full Text] [Related]
9. Novel therapeutic targets in the brain tumor microenvironment.
Phillips JJ
Oncotarget; 2012 May; 3(5):568-575. PubMed ID: 22643827
[TBL] [Abstract][Full Text] [Related]
10. Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma.
Kim Y; Kang H; Powathil G; Kim H; Trucu D; Lee W; Lawler S; Chaplain M
PLoS One; 2018; 13(10):e0204865. PubMed ID: 30286133
[TBL] [Abstract][Full Text] [Related]
11. Decoding the Matrix: Instructive Roles of Proteoglycan Receptors.
Neill T; Schaefer L; Iozzo RV
Biochemistry; 2015 Aug; 54(30):4583-98. PubMed ID: 26177309
[TBL] [Abstract][Full Text] [Related]
12. A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR.
Al-Mayhani TF; Heywood RM; Vemireddy V; Lathia JD; Piccirillo SGM; Watts C
Neuro Oncol; 2019 Jun; 21(6):719-729. PubMed ID: 30590711
[TBL] [Abstract][Full Text] [Related]
13. Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma.
Bougnaud S; Golebiewska A; Oudin A; Keunen O; Harter PN; Mäder L; Azuaje F; Fritah S; Stieber D; Kaoma T; Vallar L; Brons NH; Daubon T; Miletic H; Sundstrøm T; Herold-Mende C; Mittelbronn M; Bjerkvig R; Niclou SP
Oncotarget; 2016 May; 7(22):31955-71. PubMed ID: 27049916
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.
Sanderson RD; Yang Y; Kelly T; MacLeod V; Dai Y; Theus A
J Cell Biochem; 2005 Dec; 96(5):897-905. PubMed ID: 16149080
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
[TBL] [Abstract][Full Text] [Related]
16. A leak pathway for luminal protons in endosomes drives oncogenic signalling in glioblastoma.
Kondapalli KC; Llongueras JP; Capilla-González V; Prasad H; Hack A; Smith C; Guerrero-Cázares H; Quiñones-Hinojosa A; Rao R
Nat Commun; 2015 Feb; 6():6289. PubMed ID: 25662504
[TBL] [Abstract][Full Text] [Related]
17. Measuring sulfatase expression and invasion in glioblastoma.
Wade A; Engler JR; Tran VM; Phillips JJ
Methods Mol Biol; 2015; 1229():507-16. PubMed ID: 25325976
[TBL] [Abstract][Full Text] [Related]
18. Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth.
Woerner BM; Luo J; Brown KR; Jackson E; Dahiya SM; Mischel P; Benovic JL; Piwnica-Worms D; Rubin JB
Mol Cancer Res; 2012 Jan; 10(1):156-66. PubMed ID: 22086906
[TBL] [Abstract][Full Text] [Related]
19. Heparanase Promotes Glioma Progression and Is Inversely Correlated with Patient Survival.
Kundu S; Xiong A; Spyrou A; Wicher G; Marinescu VD; Edqvist PD; Zhang L; Essand M; Dimberg A; Smits A; Ilan N; Vlodavsky I; Li JP; Forsberg-Nilsson K
Mol Cancer Res; 2016 Dec; 14(12):1243-1253. PubMed ID: 27565180
[TBL] [Abstract][Full Text] [Related]
20. Heparan Sulfate Glycosaminoglycans in Glioblastoma Promote Tumor Invasion.
Tran VM; Wade A; McKinney A; Chen K; Lindberg OR; Engler JR; Persson AI; Phillips JJ
Mol Cancer Res; 2017 Nov; 15(11):1623-1633. PubMed ID: 28778876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
